Collagen After 40: What Changes in Your Body, Why It Matters, and What to Do About It

If you've noticed your skin feeling different, your joints taking longer to recover, or your body responding to exercise in ways it didn't a few years ago, you're not imagining it. Something real is happening, and it's happening faster than most people expect.

After 40, falling estrogen levels trigger an accelerated loss of collagen across multiple tissues simultaneously. It's not one change. It's three, affecting your skin, your joints, and your bones at the same time, each requiring a different solution.

Understanding what's actually happening, and why generic collagen supplements often miss the mark, is the first step toward doing something effective about it.

Key takeaways:

• Women can lose up to 30% of their skin collagen in the first five years after menopause, with the majority of that loss concentrated in the first one to two years.

• Collagen decline after 40 affects skin, joints, and bones through different biological mechanisms. Each requires a targeted peptide solution, not a generic collagen supplement.

• Clinical evidence exists for specific bioactive peptide technologies in postmenopausal women. FORTIBONE® increased bone mineral density by 4.2% in the spine and 7.7% in the femoral neck over 12 months in a double-blind RCT.

• The right protocol is goal-matched. One product does not address all three areas.

Estrogen does far more than regulate reproductive health. It actively stimulates collagen-producing cells called fibroblasts, supports skin thickness and elasticity, maintains joint cartilage integrity, and helps regulate bone remodeling. When estrogen declines during perimenopause and menopause, collagen production doesn't just slow gradually. It drops sharply.

A 2025 PMC narrative review on menopausal skin changes confirmed that skin collagen content declines at an average rate of 2.1% per postmenopausal year, with skin elasticity falling 1.5% per year. Research consistently shows women can lose up to 30% of their skin collagen within the first five years after menopause, with most of that loss concentrated in the first one to two years.

What this means in practice: the changes many women notice around 40 to 45, skin that feels thinner or less firm, joints that take longer to recover, a sense that the body is responding differently, are not vague or imagined. They are measurable, biologically driven, and directly linked to hormonal change.

This is not a personal failure. It's a physiological shift that every woman goes through. The question is whether you're addressing it with something that actually matches the biology, or with something that sounds plausible but doesn't.

Why collagen loss after 40 is not one problem

Most articles about collagen and menopause treat it as a single issue. Take collagen, feel better. The reality is more specific.

Estrogen loss triggers collagen decline in three distinct tissue systems, each with different mechanisms and different clinical evidence:

The key insight: a generic collagen supplement labeled "Type I, II, and III" doesn't contain any of these specific peptide technologies. It provides amino acids. The targeted biological signaling that drives measurable outcomes in skin, cartilage, and bone comes from named, clinically studied peptide formulations, not from generic hydrolyzed collagen.

The clinical data for each of these tissue areas is more specific than most collagen marketing suggests. Here's what the research actually shows, and why it matters for women in their 40s and 50s.

Skin: VERISOL® and the elasticity evidence

A double-blind, placebo-controlled trial in 69 women aged 35 to 55 found that 2.5g of VERISOL® daily for 8 weeks produced a statistically significant 15% improvement in skin elasticity compared to placebo. A follow-up study in 114 women aged 45 to 65 showed a 32% reduction in eye wrinkle volume after 8 weeks and a 65% increase in pro-collagen type I synthesis.

What makes VERISOL® different: it's produced through controlled hydrolysis to create specific peptide sequences that bind to receptors in the dermis and actively stimulate fibroblast activity. Generic marine or bovine collagen doesn't have these defined sequences or the clinical evidence behind them.

Joints: FORTIGEL® and cartilage-related outcomes

A Penn State study of 147 athletes experiencing activity-related joint pain showed statistically significant improvements after 24 weeks of FORTIGEL®. A separate Harvard and Tufts Medical Center study using MRI confirmed visible cartilage-related outcomes over 48 weeks. For women over 40 who are still active, this matters: joint stiffness and slower post-exercise recovery are among the most common complaints, and they have a specific peptide solution.

Bones: FORTIBONE® and the postmenopausal RCT

This is the data point most competitors miss entirely. A 12-month randomised, double-blind, placebo-controlled trial published in Nutrients enrolled 131 postmenopausal women with age-related bone mineral density reductions. Women taking 5g of FORTIBONE® daily showed 4.2% higher BMD in the spine and 7.7% higher BMD in the femoral neck compared to the placebo group. Bone formation markers increased significantly; bone degradation markers decreased. A 4-year follow-up confirmed progressive improvements continued over time, with zero fractures recorded.

The practical significance: the placebo group's BMD continued to decline over the study period, which is the expected trajectory without intervention. The FORTIBONE® group reversed that trend. For women in their 40s and 50s, this is the window when proactive support matters most.

The right protocol depends on which area is your primary concern, though many women over 40 benefit from addressing more than one.

For skin elasticity, hydration, and visible aging

BeMe GLOW uses VERISOL® at 2.5g alongside CoQ10, vitamin C, and vitamin E. It's built specifically for women 35 and over who want clinical-grade skin support rather than generic beauty collagen. Results in skin elasticity and wrinkle reduction typically become measurable at 4 to 8 weeks of consistent daily use.

For joint comfort and cartilage support

BeMe MOVE combines FORTIGEL® and FORTIBONE® at 10g total, addressing both cartilage and bone in a single daily sachet. For women who are active, whether that's running, strength training, yoga, or simply staying mobile through a demanding day, this is the most clinically supported option for joint and skeletal longevity.

For a complete active aging protocol

The full BeMe Wellness range allows you to match peptide protocols to your specific goals. GLOW for skin. MOVE for joints and bones. PROTECT for tendons and ligaments if you're managing repetitive load from exercise. Each product uses a named GELITA bioactive peptide technology at the exact dose used in the clinical studies behind it.

The format advantage: BeMe's liquid sachets make it straightforward to take 10 to 15g of clinically dosed peptides daily, without the pill burden that comes with capsule-based collagen or the preparation required for powders. Consistency over 12 to 24 weeks is what drives the structural outcomes the research shows. The format has to survive real life for that to happen.

The Bottom Line: Informed Action, Not Alarm

The changes that come with perimenopause and menopause are real, biologically driven, and well-documented. They're also addressable, not with generic supplements that promise everything and specify nothing, but with named peptide technologies that have been clinically tested in women at exactly this life stage.

The conversation about collagen after 40 should not be about fear of aging. It should be about having the right information to make a genuinely effective choice.

• Skin: VERISOL® at 2.5g daily, with clinical evidence in women aged 35 to 65.

• Joints and cartilage: FORTIGEL® at 5-10g daily, with evidence for pain reduction and MRI-confirmed cartilage-related outcomes.

• Bones: FORTIBONE® at 5g daily, with a 12-month RCT in postmenopausal women showing 7.7% higher femoral neck BMD vs placebo.

These are not the same as "collagen peptides" or "hydrolyzed collagen" on a generic label. They are specific, named technologies with specific clinical outcomes in specific populations.

Explore the full BeMe Wellness range to find the protocol matched to your goals, whether that's skin, joints, bones, or all three.